Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Amgen Inc (NASDAQ:AMGN)

169.84
Delayed Data
As of 4:00pm ET
 +1.05 / +0.62%
Today’s Change
138.83
Today|||52-Week Range
191.10
+16.16%
Year-to-Date
AMGN Regular Dividend: AMGN began trading ex-dividend on 11/16/17. A $1.15 dividend will be paid to shareholders of record as of 11/17/17.

Today’s Trading

Previous close168.79
Today’s open169.35
Day’s range168.89 - 170.49
Volume128,390
Average volume (3 months)2,606,317
Market cap$122.5B
Dividend yield2.71%
Data as of 4:00pm ET, 11/21/2017

Growth & Valuation

Earnings growth (last year)+13.02%
Earnings growth (this year)+8.88%
Earnings growth (next 5 years)+4.17%
Revenue growth (last year)+6.31%
P/E ratio15.3
Price/Sales4.86
Price/Book4.17

Competitors

 Today’s
change
Today’s
% change
GILDGilead Sciences+0.38+0.53%
BIIBBiogen-0.40-0.13%
ILMNIllumina Inc+1.38+0.66%
----
Data as of 4:00pm ET, 11/21/2017

Financials

Next reporting dateJanuary 25, 2018
EPS forecast (this quarter)$3.03
Annual revenue (last year)$22.7B
Annual profit (last year)$7.7B
Net profit margin34.04%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman &
Chief Executive Officer
Robert A. Bradway
Executive Vice President-
Operations
Esteban Santos
Corporate headquarters
Thousand Oaks, California

Forecasts